Cargando…

Potential application of the haematology analyser XN-31 prototype for field malaria surveillance in Kenya

BACKGROUND: Simple and accurate diagnosis is a key component of malaria control programmes. Microscopy is the current gold standard, however it requires extensive training and the results largely rely on the skill of the microscopists. Malaria rapid diagnostic tests (RDT) can be performed with minim...

Descripción completa

Detalles Bibliográficos
Autores principales: Kagaya, Wataru, Takehara, Ikki, Kurihara, Kyoko, Maina, Michael, Chan, Chim W., Okomo, Gordon, Kongere, James, Gitaka, Jesse, Kaneko, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434510/
https://www.ncbi.nlm.nih.gov/pubmed/36050757
http://dx.doi.org/10.1186/s12936-022-04259-7
_version_ 1784780882945507328
author Kagaya, Wataru
Takehara, Ikki
Kurihara, Kyoko
Maina, Michael
Chan, Chim W.
Okomo, Gordon
Kongere, James
Gitaka, Jesse
Kaneko, Akira
author_facet Kagaya, Wataru
Takehara, Ikki
Kurihara, Kyoko
Maina, Michael
Chan, Chim W.
Okomo, Gordon
Kongere, James
Gitaka, Jesse
Kaneko, Akira
author_sort Kagaya, Wataru
collection PubMed
description BACKGROUND: Simple and accurate diagnosis is a key component of malaria control programmes. Microscopy is the current gold standard, however it requires extensive training and the results largely rely on the skill of the microscopists. Malaria rapid diagnostic tests (RDT) can be performed with minimal training and offer timely diagnosis, but results are not quantitative. Moreover, some Plasmodium falciparum parasites have evolved and can no longer be detected by existing RDT. Developed by the Sysmex Corporation, the XN-31 prototype (XN-31p) is an automated haematology analyser capable of detecting Plasmodium-infected erythrocytes and providing species differentiation and stage specific parasite counts in venous blood samples without any preparation in approximately one minute. However, factors such as stable electricity supply in a temperature-controlled room, cost of the instrument and its initial set-up, and need for proprietary reagents limit the utility of the XN-31p across rural settings. To overcome some of these limitations, a hub and spoke diagnosis model was designed, in which peripheral health facilities were linked to a central hospital where detection of Plasmodium infections by the XN-31p would take place. To explore the feasibility of this concept, the applicability of capillary blood samples with the XN-31p was evaluated with respect to the effect of sample storage time and temperature on the stability of results. METHODS: Paired capillary and venous blood samples were collected from 169 malaria-suspected outpatients in Homa Bay County Referral Hospital, Kenya. Malaria infections were diagnosed with the XN-31p, microscopy, RDT, and PCR. Capillary blood samples were remeasured on the XN-31p after 24 h of storage at either room (15–25 °C) or chilled temperatures (2–8 °C). RESULTS: Identical results in malaria diagnosis were observed between venous and capillary blood samples processed immediately after collection with the XN-31p. Relative to PCR, the sensitivity and specificity of the XN-31p with capillary blood samples were 0.857 and 1.000, respectively. Short-term storage of capillary blood samples at chilled temperatures had no adverse impact on parasitaemia and complete blood counts (CBC) measured by the XN-31p. CONCLUSION: These results demonstrate the potential of the XN-31p to improve routine malaria diagnosis across remote settings using a hub and spoke model. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-022-04259-7.
format Online
Article
Text
id pubmed-9434510
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94345102022-09-01 Potential application of the haematology analyser XN-31 prototype for field malaria surveillance in Kenya Kagaya, Wataru Takehara, Ikki Kurihara, Kyoko Maina, Michael Chan, Chim W. Okomo, Gordon Kongere, James Gitaka, Jesse Kaneko, Akira Malar J Research BACKGROUND: Simple and accurate diagnosis is a key component of malaria control programmes. Microscopy is the current gold standard, however it requires extensive training and the results largely rely on the skill of the microscopists. Malaria rapid diagnostic tests (RDT) can be performed with minimal training and offer timely diagnosis, but results are not quantitative. Moreover, some Plasmodium falciparum parasites have evolved and can no longer be detected by existing RDT. Developed by the Sysmex Corporation, the XN-31 prototype (XN-31p) is an automated haematology analyser capable of detecting Plasmodium-infected erythrocytes and providing species differentiation and stage specific parasite counts in venous blood samples without any preparation in approximately one minute. However, factors such as stable electricity supply in a temperature-controlled room, cost of the instrument and its initial set-up, and need for proprietary reagents limit the utility of the XN-31p across rural settings. To overcome some of these limitations, a hub and spoke diagnosis model was designed, in which peripheral health facilities were linked to a central hospital where detection of Plasmodium infections by the XN-31p would take place. To explore the feasibility of this concept, the applicability of capillary blood samples with the XN-31p was evaluated with respect to the effect of sample storage time and temperature on the stability of results. METHODS: Paired capillary and venous blood samples were collected from 169 malaria-suspected outpatients in Homa Bay County Referral Hospital, Kenya. Malaria infections were diagnosed with the XN-31p, microscopy, RDT, and PCR. Capillary blood samples were remeasured on the XN-31p after 24 h of storage at either room (15–25 °C) or chilled temperatures (2–8 °C). RESULTS: Identical results in malaria diagnosis were observed between venous and capillary blood samples processed immediately after collection with the XN-31p. Relative to PCR, the sensitivity and specificity of the XN-31p with capillary blood samples were 0.857 and 1.000, respectively. Short-term storage of capillary blood samples at chilled temperatures had no adverse impact on parasitaemia and complete blood counts (CBC) measured by the XN-31p. CONCLUSION: These results demonstrate the potential of the XN-31p to improve routine malaria diagnosis across remote settings using a hub and spoke model. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-022-04259-7. BioMed Central 2022-09-01 /pmc/articles/PMC9434510/ /pubmed/36050757 http://dx.doi.org/10.1186/s12936-022-04259-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kagaya, Wataru
Takehara, Ikki
Kurihara, Kyoko
Maina, Michael
Chan, Chim W.
Okomo, Gordon
Kongere, James
Gitaka, Jesse
Kaneko, Akira
Potential application of the haematology analyser XN-31 prototype for field malaria surveillance in Kenya
title Potential application of the haematology analyser XN-31 prototype for field malaria surveillance in Kenya
title_full Potential application of the haematology analyser XN-31 prototype for field malaria surveillance in Kenya
title_fullStr Potential application of the haematology analyser XN-31 prototype for field malaria surveillance in Kenya
title_full_unstemmed Potential application of the haematology analyser XN-31 prototype for field malaria surveillance in Kenya
title_short Potential application of the haematology analyser XN-31 prototype for field malaria surveillance in Kenya
title_sort potential application of the haematology analyser xn-31 prototype for field malaria surveillance in kenya
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434510/
https://www.ncbi.nlm.nih.gov/pubmed/36050757
http://dx.doi.org/10.1186/s12936-022-04259-7
work_keys_str_mv AT kagayawataru potentialapplicationofthehaematologyanalyserxn31prototypeforfieldmalariasurveillanceinkenya
AT takeharaikki potentialapplicationofthehaematologyanalyserxn31prototypeforfieldmalariasurveillanceinkenya
AT kuriharakyoko potentialapplicationofthehaematologyanalyserxn31prototypeforfieldmalariasurveillanceinkenya
AT mainamichael potentialapplicationofthehaematologyanalyserxn31prototypeforfieldmalariasurveillanceinkenya
AT chanchimw potentialapplicationofthehaematologyanalyserxn31prototypeforfieldmalariasurveillanceinkenya
AT okomogordon potentialapplicationofthehaematologyanalyserxn31prototypeforfieldmalariasurveillanceinkenya
AT kongerejames potentialapplicationofthehaematologyanalyserxn31prototypeforfieldmalariasurveillanceinkenya
AT gitakajesse potentialapplicationofthehaematologyanalyserxn31prototypeforfieldmalariasurveillanceinkenya
AT kanekoakira potentialapplicationofthehaematologyanalyserxn31prototypeforfieldmalariasurveillanceinkenya